Skip to content

Validation of homoeopathic drugs for piles

Validation of commonly used homoeopathic drugs for haemorrhoids: A prospective observational study

Status
Recruiting
Phases
Phase 3
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013451
Enrollment
200
Registered
2018-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Haemorrhoids

Interventions

Sponsors

Central Council for Research in Homoeopathy New Delhi Ministry of AYUSH Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Internal haemorrhoids diagnosed as per ICD 10 grade criteria (Code K64): 2. First degree haemorrhoids: Grade/stage I haemorrhoids â?? Haemorrhoids (bleeding) without prolapse outside of anal canal 3. Second degree haemorrhoids: Grade/stage II haemorrhoids â?? Haemorrhoids (bleeding) that prolapse with straining, but retract spontaneously 4. With any of the following clinical symptoms: bleeding, pain (including discomfort and tenesmus during defecation or any other time), heaviness, pruritus, and mucus discharge.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women 2. External hemorrhoids 3. Skin tags 4. Malignancies 5. Rectal polyps 6. Anal fissure 7. Irritable bowel syndrome 8. On allopathic drugs, other than for hypertension or diabetes mellitus 9. Other ongoing treatment which is likely to interfere with the course of this treatment.

Design outcomes

Primary

MeasureTime frame
To observe the change in sodergren score at the end of 6 months of treatment.Timepoint: Baseline, 6 months

Secondary

MeasureTime frame
To observe the change in Quality of Life (WHO-QOL) at the end of 6 months of treatment.Timepoint: Baseline, 6 months

Countries

India

Contacts

Public ContactDr R K Manchanda

Central Council for Research in Homoeopathy

anilnaman@rediffmail.com011-28524266

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026